CABA on Nasdaq
Cabaletta Bio, Inc.
$1.55 down 0.07 (4.32%)Price as of Oct 15, 2026 at 17:33 UTC
Last updated Oct 16, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
Every line of the income statement in the latest annual report, as filed.9
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Research and development | $142.7M | $97.2M |
| General and administrative | $29.6M | $27.9M |
| Total operating expenses | $172.2M | $125.1M |
| Loss from operations | -$172.2M | -$125.1M |
| Interest income | $6.0M | $10.0M |
| Interest expense | -$2.0M | -$748.0K |
| Other income, net | $358.0K | $0 |
| Net loss | -$167.9M | -$115.9M |
| Net unrealized gain (loss) on available-for-sale investments, net of tax | $25.0K | -$39.0K |
| Net comprehensive loss | -$167.8M | -$115.9M |
| Net loss per share of voting and non-voting common stock, basic | -$2.10 | -$2.34 |
| Net loss per share of voting and non-voting common stock, diluted | -$2.10 | -$2.34 |
Every line of the balance sheet in the latest annual report, as filed.9
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $83.0M | $164.0M | |
| Short-term investments | $50.6M | $0 | |
| Prepaid expenses and other current assets | $5.3M | $2.7M | |
| Total current assets | $138.9M | $166.7M | |
| Property and equipment, net | $1.9M | $2.7M | |
| Finance lease right-of-use assets | $15.7M | $7.0M | |
| Operating lease right-of-use assets | $3.4M | $6.3M | |
| Other assets | $5.2M | $2.3M | |
| Total Assets | $165.1M | $185.0M | |
| Accounts payable | $6.6M | $4.9M | |
| Accrued and other current liabilities | $19.3M | $12.2M | |
| Finance lease liabilities, current portion | $20.8M | $6.0M | |
| Operating lease liabilities, current portion | $3.5M | $4.0M | |
| Total current liabilities | $50.2M | $27.1M | |
| Finance lease liabilities, net of current portion | $2.9M | $3.2M | |
| Operating lease liabilities, net of current portion | $0 | $2.4M | |
| Total Liabilities | $53.0M | $32.7M | |
| Preferred stock, $0.00001 par value: 10,000,000 shares authorized as of December 31, 2025 and December 31, 2024; no shares issued or outstanding at December 31, 2025 and December 31, 2024 | $0 | $0 | |
| Voting and non-voting common stock, $0.00001 par value: 300,000,000 (293,590,481 voting and 6,409,519 non-voting) shares authorized as of December 31, 2025 and 150,000,000 (143,590,481 voting and 6,409,519 non-voting) shares authorized as of December 31, 2024; 100,479,323 voting shares issuedand outstanding as of December 31, 2025 and 50,743,101voting shares issued and outstanding as of December 31, 2024 | $1.0K | $1.0K | |
| Additional paid-in capital | $629.0M | $501.4M | |
| Accumulated other comprehensive income | $25.0K | $0 | |
| Accumulated deficit | -$517.0M | -$349.1M | |
| Total stockholders equity | $112.1M | $152.3M | $236.2M |
| Total liabilities and stockholders equity | $165.1M | $185.0M | |
| Preferred stock, par value | $0.00 | $0.00 | |
| Preferred stock, authorized shares | 10.0M shares | 10.0M shares | |
| Preferred stock, issued shares | 0 shares | 0 shares | |
| Preferred stock, outstanding shares | 0 shares | 0 shares | |
| Common stock, authorized shares | 300.0M shares | 150.0M shares | |
| Common stock, issued shares | 100.5M shares | 50.7M shares | |
| Common stock, outstanding shares | 100.5M shares | 50.7M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.9
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss | -$167.9M | -$115.9M |
| Stock-based compensation | $20.9M | $19.5M |
| Depreciation | $1.6M | $1.7M |
| Non-cash finance lease expense | $11.7M | $3.1M |
| Non-cash operating lease expense | $3.7M | $2.8M |
| Accretion of operating lease liabilities | $532.0K | $405.0K |
| Amortization of discount on investments | -$1.6M | -$1.5M |
| Loss on foreign currency exchange rates | $225.0K | $38.0K |
| Prepaid expenses and other current assets | -$2.6M | $528.0K |
| Other assets | -$2.9M | -$584.0K |
| Accounts payable | $1.6M | $1.0M |
| Accrued and other current liabilities | $7.4M | $3.9M |
| Lease liabilities | -$4.2M | -$3.3M |
| Accrued interest payable under finance lease | $291.0K | $0 |
| Net cash used in operating activities | -$131.1M | -$88.2M |
| Purchases of property and equipment | -$1.2M | -$2.2M |
| Purchases of investments | -$99.0M | $0 |
| Proceeds from maturities of investments | $50.0M | $49.5M |
| Net cash (used in) provided by investing activities | -$50.3M | $47.3M |
| Proceeds from the issuance of common stock, warrants and pre-funded warrants, net of issuance costs | $93.6M | $0 |
| Issuance of common stock from ATM offering, net of sales agent commission and fees | $12.7M | $10.9M |
| Proceeds from the issuance of common stock under employee stock purchase plan | $291.0K | $269.0K |
| Proceeds from issuance of common stock in connection with the exercise of stock options | $14.0K | $1.4M |
| Principal payments on finance leases | -$6.3M | -$897.0K |
| Net cash provided by financing activities | $100.3M | $11.7M |
| Effect of exchange rate changes on cash and cash equivalents | $19.0K | -$20.0K |
| Net decrease in cash and cash equivalents | -$81.0M | -$29.3M |
| Cash paid for interest | $1.7M | $748.0K |
| Property and equipment purchases included in accounts payable and accrued expenses | $0 | $404.0K |
| Right-of use assets obtained in exchange for lease obligations | $21.1M | $11.0M |
| Right-of-use assets obtained in exchange for operating lease obligations | $787.0K | $4.2M |
Recent filings
- Sep 14, 20268-K
- Aug 14, 2026SCHEDULE 13G/A
- Aug 14, 2026SCHEDULE 13G/A
- Aug 14, 2026SCHEDULE 13G/A
- Aug 13, 20268-K
- Aug 13, 202610-Q
- Aug 12, 2026SCHEDULE 13G
- Aug 12, 2026SCHEDULE 13G/A
- Jul 31, 2026SCHEDULE 13G
- Jul 27, 2026SCHEDULE 13G
- Jul 23, 2026SCHEDULE 13G/A
- Jun 11, 20268-K
- Jun 10, 20264
- Jun 10, 20264
- Jun 10, 20264
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2Yahoo FinanceCABA quote
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11